by Simona Gilman | Jun 25, 2020 | Featured Posts, Press Releases
A transformative innovation GeminiTM, the in silico patient, will drive better drug development, clinical trial design and generation of real-world evidence in multiple myeloma GNS Healthcare, an AI-driven precision medicine company, today announced the launch of...
by Simona Gilman | Jun 18, 2020 | Press Releases
Partnership Aims to Answer Key Questions in Multiple Myeloma Patient Care and Accelerate Discovery and Development of New Treatments Cambridge, MA – June 18, 2020– GNS Healthcare and the Multiple Myeloma Research Foundation (MMRF) today announced a five-year...
by Simona Gilman | May 28, 2020 | Press Releases
Study results are from the DREAM Challenge and are published in Leukemia CAMBRIDGE, Mass.– May 28, 2020 – GNS Healthcare (GNS), a leading AI-driven precision medicine, announced results of a recently published collaboration that uncovered transcription factor PHF19 as...
by Simona Gilman | Apr 21, 2020 | Press Releases
Michael Bonney, Tom Daniel, Peter Neupert, and Lee Newcomer join GNS Healthcare’s in silico Patient Advisory Board Cambridge, MA – April 21, 2020 – GNS Healthcare, an AI-driven precision medicine company, is pleased to announce the formation of its in silico Patient...
by Simona Gilman | Apr 14, 2020 | Press Releases
CAMBRIDGE, Mass.– April 14, 2020 – GNS Healthcare (GNS) is pleased to announce that Dr. Earl Steinberg, a nationally recognized expert in population health management, data analytics, and clinical informatics, has joined the company’s leadership team as a consultant...
by Simona Gilman | Jan 5, 2020 | Featured Posts, Press Releases
Merck GHI joins leading biopharma companies Amgen, BMS, Zambon Pharmaceuticals, and leading health plans Cigna, Cambia Health Solutions, Echo Health Ventures, Horizon Blue Cross of NJ, and Heritage Provider Network, as an investor in GNS Healthcare. CAMBRIDGE, Mass. –...
